See other companies on Otta
Field Trip Health
Psychedelic based therapy
- 101-200 employees
- B2C
- Retail
- B2B
- Mental health
- 30 Duncan Street, Suite 400, Toronto, ON, M5V 2C3
Jump to section
Company mission
To advance the field of therapeutic psychedelics and bring people to life
Otta's take
Xav Kearney
CTO of Otta
The market for psychedelic-based therapy services in North America has exploded since the cautious legalisation of Ketamine in psychiatric practices across the continent
Field Trip is leading the field in this area. The company has focused on delivering an integrative treatment through a combination of virtual and in-person therapeutic meetings aided by the presence of a Ketamine drip
While the startup seeks to roll-out its practices to even more regions across the US and Canada, the company is also keen to explore the opportunities of other psychedelic substances through its research division
The biggest challenge for Field Trip will be pushing their services down the cost curve to truly democratise access to their remarkable treatments
Company values
- Bringing people to life
- Providing simple access to all
- Making anything possible
Funding (2 rounds)
Aug 2020
$11m
SERIES B
Feb 2020
$8.5m
SERIES A
$19.5m
Total funding
Founders
Joseph del Moral
(CEO)Previously founder and CEO of CanvasRx and Canadian Cannabis Clinics. Joined Aurura Cannabis board after CanvasRx was acquired by Aurora Cannabis. Went on to be CEO of Trait Biosciences, a cannabis biotechnology company before co-founding Field Trip.
Mujeeb Jaffrei
(COO)Served as Vice President of Sales Strategy and Operations at Just Energy and President of its Solar Energy division. Has held senior leadership roles in areas of corporate finance, operations, strategy and business development at Just Energy and SunEdison.
Ronan Levy
(Executive Chairman)Concurrent with his work at Field Trip, is a partner at Grassfed Ventures, a venture capital and advisory firm focused on the cannabis and biotech industries and is Chief Strategy Officer and Member of the Board of Directors for Trait Biosciences, a leading biotech company in the hemp and cannabis industries.